Patents Examined by James S. Schultz
  • Patent number: 6524581
    Abstract: The present invention relates to methods of treating retinopathy, retinal ischemia and/or retinal edema comprising administering an integrin or integrin subunit antagonist, leukocyte adhesion-inducing cytokine antagonist or growth factor antagonist, a selectin antagonist or adhesion molecule antagonist.
    Type: Grant
    Filed: December 29, 1999
    Date of Patent: February 25, 2003
    Assignee: The Children's Medical Center Corporation
    Inventor: Anthony P. Adamis